Humulin R U-500 500 [iU]/mL (Insulin human INJECTION, SOLUTION) 500 [iU]/mL

Insulin human, the active ingredient in Humulin R U-500, works by activating insulin receptors in the body. This promotes the uptake of glucose by cells, enhances glucose utilization, and inhibits hepatic glucose production. By mimicking the action of natural insulin, it helps to lower blood glucose levels and manage diabetes effectively.

The dosage of Humulin R U-500 is determined by a healthcare professional based on individual patient needs, blood glucose levels, and response to therapy. It is crucial to follow the prescribed dosage and adjust it as directed by the healthcare provider to avoid hypoglycemia or hyperglycemia.

Humulin R U-500 is classified as pregnancy category B, indicating that no proven risk in humans has been established. However, it should be used during pregnancy only if clearly needed and under medical supervision. For breastfeeding, the safety of Humulin R U-500 has not been fully established, and caution is advised. Always consult a healthcare provider before using this medication during pregnancy or breastfeeding.

To order Humulin R U-500 from GNH India, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will then provide pricing, availability, shipping details (including cold-chain logistics where relevant), and the necessary import paperwork.

Humulin R U-500 is a short-acting insulin used for managing diabetes in patients with high insulin requirements, while Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes. Humulin R U-500 requires subcutaneous injection and has a rapid onset of action, whereas Ozempic is administered once weekly and works by increasing insulin secretion and reducing glucose production in the liver.

Humulin R U-500 should be stored at 2-8°C, refrigerated, and protected from light. It should not be frozen or shaken. Always keep the medication in its original packaging until use. Proper storage is essential to maintain the efficacy and safety of the medication.

Humulin R U-500 is administered subcutaneously, typically in the abdomen, thigh, or upper arm. It is essential to rotate injection sites to prevent lipodystrophy. The medication should be injected using a syringe specifically designed for U-500 insulin to ensure accurate dosing. Always follow the healthcare provider's instructions for administration.

The most serious risks associated with Humulin R U-500 include severe hypoglycemia, allergic reactions, and hypersensitivity reactions. Symptoms of severe hypoglycemia include confusion, loss of consciousness, and seizures. Allergic reactions can manifest as rash, itching, or difficulty breathing. Immediate medical attention is required if any of these symptoms occur.

Humulin R U-500 should not be used by individuals who are allergic to insulin human or any of the excipients in the formulation. It should be used with caution in patients with hypoglycemia unawareness, severe renal or hepatic impairment, and in the elderly. Always consult a healthcare provider before starting Humulin R U-500 to ensure it is suitable for your medical condition.